What are the etiologies and mechanisms of formation of kidney cysts?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Kidney Cyst Etiology and Formation Mechanisms

Kidney cysts arise from diverse genetic and acquired etiologies, with the majority of inherited cystic kidney diseases stemming from mutations in genes encoding ciliary proteins that disrupt fundamental cellular processes including proliferation, fluid secretion, epithelial polarity, and extracellular matrix remodeling.

Genetic Etiologies

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

The most common inherited cause of kidney cysts is ADPKD, with PKD1 and PKD2 mutations accounting for >90% of diagnosed families 1. These genes encode polycystin-1 and polycystin-2, which form a receptor/channel complex on primary cilia 2. When function of this complex falls below a critical threshold, cyst initiation is triggered 2.

Minor ADPKD genes with definitive-to-moderate evidence include 1:

  • IFT140 (1-2% of families): Few large bilateral cysts, kidney function often preserved
  • GANAB (<0.5%): Mild PKD with limited CKD progression
  • DNAJB11 (<0.5%): Small bilateral cysts with progressive CKD
  • ALG5, ALG9, NEK8 (each <0.5%): Variable presentations

A recent pediatric cohort study found that 79% of families with kidney cysts had a monogenic diagnosis, with PKD1 variants most common (45%), followed by HNF1B/17q12 deletions (13%), and minor ADPKD genes (11%) 3. This highlights the genetic diversity beyond the major PKD1/PKD2 genes.

Other Inherited Cystic Diseases

Autosomal recessive polycystic kidney disease (ARPKD) results from mutations in PKHD1, DZIP1L, CYS1, or PKD1 (biallelic) 1. The PKHD1 gene product (fibrocystin) functions as an adhesion molecule 4.

Syndromic ciliopathies include nephronophthisis (NPHP genes), Joubert syndrome, Bardet-Biedl syndrome, and others—all involving ciliary dysfunction 1, 5.

Developmental disorders such as HNF1B-related kidney disease can present with cysts 1.

Collagen disorders (COL4A genes) and tumorous disorders (TSC1/TSC2, VHL, FLCN) may also manifest with kidney cysts 1.

Acquired Cystic Disease

Simple cysts occur sporadically with no genetic basis 1. In children, simple cysts have a reported prevalence of 0.22-1% on ultrasound, though true prevalence may differ 6.

Acquired cystic disease (ACD) develops in the setting of chronic kidney disease and dialysis 1.

Mechanisms of Cyst Formation

Ciliary Dysfunction as the Unifying Pathway

Primary cilia dysfunction represents the common denominator across most inherited cystic kidney diseases 5. The cilium functions in mechanosensation, chemosensation, and transduction of multiple signaling cascades 5.

Cellular Mechanisms

Cyst formation involves dysregulation of multiple fundamental processes 7, 8:

1. Inappropriate epithelial hyperproliferation: Cyst-lining epithelia demonstrate increased proliferation rates. In ARPKD models, cystic epithelia show nuclear YAP/TAZ accumulation (indicating suppressed Hippo pathway activity) and enhanced Src/STAT3 signaling with Y705-phosphorylated STAT3 in nuclei 9.

2. Fluid secretion: Tubular epithelial cells switch from reabsorptive to secretory phenotype, driving cyst expansion 8.

3. Defects in epithelial polarity: Loss of normal apical-basal polarity disrupts tubular architecture 7.

4. Altered cell-matrix and cell-cell interactions: Both polycystin-1 and fibrocystin act as adhesion molecules. Disruption of these interactions and extracellular matrix remodeling contribute to cyst development 7, 4.

5. Dysregulated apoptosis: Enhanced apoptosis occurs in cystic epithelia 7, 9.

Molecular Pathways

Polycystin complex dysfunction: Polycystin-2 (PKD2 product) requires polycystin-1 (PKD1 product) to translocate to the plasma membrane 4. Polycystin-1 requires TSC2 for plasma membrane transport, explaining why TSC2 mutations cause cysts 4.

Loss of function threshold: Studies suggest a "two-hit" mechanism where cyst initiation requires loss of function below an indeterminate threshold, ultimately dysregulating multiple metabolic processes and downstream pathways 2.

Noncell autonomous factors may also promote cyst growth, including macrophage recruitment and fibrotic remodeling observed in animal models 9.

Clinical Implications

Important caveat: In children with simple kidney cysts, unilateral cysts are more commonly associated with no identifiable genetic diagnosis (26% vs 4% in those with genetic diagnoses), while positive family history strongly predicts genetic etiology (54% vs 11%) 3. This distinction is critical for determining the need for genetic testing and family screening.

Reversibility: Emerging studies suggest the cyst formation process may be reversible, though this remains an area of active investigation 2.

References

Research

Mechanisms of Cyst Development in Polycystic Kidney Disease.

Advances in kidney disease and health, 2023

Research

Monogenic Etiologies of Kidney Cysts in the Pediatric Population: An Observational Cohort Study.

Clinical journal of the American Society of Nephrology : CJASN, 2026

Research

[Pathogenesis of cystic kidney diseases].

Verhandlungen der Deutschen Gesellschaft fur Pathologie, 2002

Research

Cystic diseases of the kidney: ciliary dysfunction and cystogenic mechanisms.

Pediatric nephrology (Berlin, Germany), 2011

Research

Approach to simple kidney cysts in children.

Pediatric nephrology (Berlin, Germany), 2024

Research

Cystic disease of the kidney.

Annual review of pathology, 2007

Research

Polycystic kidney disease: I. Etiology and pathogenesis.

Hospital practice (Office ed.), 1992

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.